Evidence map›Paper›PMID 38878083›Full record

ArticleArchives of dermatological research2024

Paeoniflorin regulates RhoA/ROCK1 and Nrf2 pathways in PDLIM1-dependent or independent manners in oxidative stressed melanocytes.

Jin-Ping Yuan, Pei-Yao Zhu, Yu-Zhe Sun, Yan-Song Lu, Rui-Qun Qi, Hong-Duo Chen, Yan Wu

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jin-Ping YuanDepartment of Dermatology, The Second Affiliated Hospital of Harbin Medical University, Harbin, 150086, Heilongjiang, China.
Pei-Yao ZhuDepartment of Dermatology, Shanghai Skin Disease Hospital, Tongji University School of Medicine, 1278 Baode Road, Jing'an District, Shanghai, 200443, China.
Yu-Zhe SunDermatological Hospital, Southern Medical University, Guangzhou, 510091, Guangdong, China.
Yan-Song LuDepartment of Dermatology, General Hospital of Northern Theater Command, Shenyang, 110001, Liaoning, China.
Rui-Qun QiDepartment of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China.
Hong-Duo ChenDepartment of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China. hongduochen@hotmail.com.
Yan WuDepartment of Dermatology, The First Hospital of China Medical University, Shenyang, 110001, Liaoning, China. jlwuyan@126.com.

Funding

Pfizer's Global Medical Grants program 87970425
6 · The paper itself

Abstract

backgroundThe adhesive properties of vitiligo melanocytes have decreased under oxidative stress., cytoskeleton proteins can control cell adhesion. Paeoniflorin (PF) was proved to resist hydrogen peroxide (H

objectivesThis study was to investigate whether PF exerts anti-oxidative effect through influencing cytoskeleton markers or potential signaling pathway.

methodsHuman Oxidative Stress Plus array was used to identify the differentially expressed genes between H

resultsPF increased the expressions of PDLIM1, RhoA and ROCK1 in H

conclusionsPF regulates RhoA/ROCK1 and Nrf2 pathways in PDLIM1-dependent or independent manners in H

Indexed as

GlucosidesHydrogen PeroxideLIM Domain ProteinsMelanocytesMonoterpenesNF-E2-Related Factor 2Oxidative StressrhoA GTP-Binding Proteinrho-Associated KinasesSignal TransductionCell LineGlycosidesHumansGlucosidesGlycosidesHydrogen PeroxideLIM Domain ProteinsMonoterpenesNFE2L2 protein, humanNF-E2-Related Factor 2peoniflorinrhoA GTP-Binding ProteinRHOA protein, humanrho-Associated KinasesROCK1 protein, humanCytoskeletonPaeoniflorinPDLIM1RhoAROCK1Vitiligo

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.